Home

Magenschmerzen Optimismus Denken novaliq augentropfen Abend Erzieher Teile

EyeSol - Novaliq
EyeSol - Novaliq

Anterior Segment Company Showcase - Novaliq GmbH
Anterior Segment Company Showcase - Novaliq GmbH

Startseite - Novaliq
Startseite - Novaliq

Evotears Krople Do Oczu, HD Png Download - kindpng
Evotears Krople Do Oczu, HD Png Download - kindpng

Anterior Segment Company Showcase - Novaliq GmbH
Anterior Segment Company Showcase - Novaliq GmbH

Products - Novaliq
Products - Novaliq

Management - Novaliq
Management - Novaliq

Novatears - Novaliq
Novatears - Novaliq

Novaliq Announces Positive Topline Results for Its SEECASE Phase 2 Trial of  NOV03 for the Treatment of Patients with Dry Eye Disease | Business Wire
Novaliq Announces Positive Topline Results for Its SEECASE Phase 2 Trial of NOV03 for the Treatment of Patients with Dry Eye Disease | Business Wire

Novaliq GmbH: Geuder AG
Novaliq GmbH: Geuder AG

Novaliq's NovaTears® Treatment for Evaporative Dry Eye Disease is Now  Available across Australia and New Zealand | Business Wire
Novaliq's NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand | Business Wire

NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL  TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN  SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING

Novaliq completes enrollment in second Phase 3 study of candidate to treat  dry eye
Novaliq completes enrollment in second Phase 3 study of candidate to treat dry eye

Novaliq eyes dermatology opportunity, spinning off 3 programs and securing  $15M for clinical trials | Fierce Pharma
Novaliq eyes dermatology opportunity, spinning off 3 programs and securing $15M for clinical trials | Fierce Pharma

Investor Relation - Novaliq
Investor Relation - Novaliq

Press Releases - Novaliq
Press Releases - Novaliq

Novaliq NovaTears® +Omega-3 eye drops for Dry Eyes | AFT Pharmaceuticals
Novaliq NovaTears® +Omega-3 eye drops for Dry Eyes | AFT Pharmaceuticals

EvoTears® OMEGA - EvoTears®
EvoTears® OMEGA - EvoTears®

NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL  TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN  SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING

novaliq - Twitter Search / Twitter
novaliq - Twitter Search / Twitter

Startseite - Novaliq
Startseite - Novaliq

Novaliq schließt Rekrutierung der zweiten Phase III-Studie für CyclASol®  zur Behandlung von Trockenes Auge (Keratoconjunctivitis sicca - „KCS", oder  auch Syndrom des trockenen Auges) ab
Novaliq schließt Rekrutierung der zweiten Phase III-Studie für CyclASol® zur Behandlung von Trockenes Auge (Keratoconjunctivitis sicca - „KCS", oder auch Syndrom des trockenen Auges) ab

Anterior Segment Company Showcase - Novaliq GmbH
Anterior Segment Company Showcase - Novaliq GmbH

Anterior Segment Company Showcase - Novaliq GmbH
Anterior Segment Company Showcase - Novaliq GmbH

Products - Novaliq
Products - Novaliq

Anterior Segment Company Showcase - Novaliq GmbH
Anterior Segment Company Showcase - Novaliq GmbH

Novaliq GmbH: Geuder AG
Novaliq GmbH: Geuder AG

Novaliq: Transforming Tears (OIS@AAO 2016) - YouTube
Novaliq: Transforming Tears (OIS@AAO 2016) - YouTube